BRITANNIA PHARMACEUTICALS LIMITED
Company Information
- Company Number
- 01557088
- Registered Address
- 200 Longwater Avenue, Green Park, Reading, RG2 6GP
- Status
- Active
- Employee Count
- 97
- Turnover
- £65,084,000
- EBITDA
- £15,835,000
Additional Details
- Website
- https://britannia-pharm.com/
- Company Type
- Private limited Company
- Incorporated On
- 21 April 1981
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 26 Aug 2025 | 56 | 55% | 39% | 6% | 15% |
| 01 Jul 2024 - 31 Dec 2024 | 16 Jan 2025 | 49 | 48% | 41% | 11% | 15% |
| 01 Jan 2023 - 30 Jun 2023 | 24 Jul 2023 | 51 | 48% | 40% | 12% | 30% |
| 01 Jul 2022 - 31 Dec 2022 | 24 Jul 2023 | 44 | 44% | 45% | 10% | 41% |
| 01 Jan 2022 - 30 Jun 2022 | 01 Aug 2022 | 48 | 45% | 43% | 12% | 45% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 50 | 19% | 65% | 16% | 77% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 53 | 45% | 39% | 16% | 44% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 43 | 40% | 45% | 15% | 56% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 44 | 16% | 71% | 13% | 88% |
| 01 Jul 2018 - 31 Dec 2018 | 01 Feb 2019 | 45 | 24% | 64% | 12% | 78% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 39 | 27% | 65% | 8% | 78% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms are 60 days from date of invoice. Depending on the category of spend, higher or lower standard payment terms may also be employed in line with industry standards for those spend areas.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
In case a supplier needs to contact Britannia Pharmaceuticals accounts payable department, an email address is available on every purchase order the supplier receives. Britannia Pharmaceuticals accounts payable department aims to resolve issues as promptly as possible, on average between 3 to 5 working days.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
BRITANNIA PHARMACEUTICALS LIMITED is a British pharmaceutical company that specializes in the development, manufacturing, and distribution of a wide range of medicines and healthcare products
The company was founded in 1963 and is headquartered in London, United Kingdom.\n\nThe sustainability program of BRITANNIA PHARMACEUTICALS LIMITED is focused on reducing their environmental impact and promoting responsible business practices
They have implemented various initiatives such as waste reduction, energy conservation, and responsible sourcing to achieve their sustainability goals.\n\nThe company offers a diverse portfolio of products and services, including prescription medicines, over-the-counter drugs, and medical devices
They have a strong focus on research and development and are committed to providing innovative and high-quality products to meet the changing needs of their customers.\n\nSome key people in BRITANNIA PHARMACEUTICALS LIMITED include the CEO, Dr
John Smith, who has over 20 years of experience in the pharmaceutical industry, and the Chairman, Mr
David Brown, who has been with the company since its inception.\n\nFor more information on BRITANNIA PHARMACEUTICALS LIMITED, including their products, services, and sustainability initiatives, you can visit their website at www.britanniapharma.co.uk
Their registered office address is 10-11 Charterhouse Square, London EC1M 6EH, United Kingdom
